» Articles » PMID: 28376606

Positive Surgical Margin in Robot-assisted Radical Prostatectomy: Correlation with Pathology Findings and Risk of Biochemical Recurrence

Overview
Specialty Nephrology
Date 2017 Apr 6
PMID 28376606
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To analyze the correlation of surgical margin status with other findings on final pathology and risk of biochemical recurrence (BCR) in patients undergoing robot-assisted radical prostatectomy (RALP).

Methods: Bundang Prostatectomy Database was reviewed to identify patients who underwent RARP from 2007 to 2011 and had a positive surgical margin (PSM) on final pathology. Pathology findings were reviewed. BCR-free survival was calculated using the Kaplan-Meier method. Cox univariable and multi-variable regression models were used to find the correlation between clinicopathologic factors and BCR.

Results: Eight hundred and fifteen patients were included in the analysis: 118 (14.48%) had apical positive margin, 152 (18.65%) had a positive margin in another site, and 545 (66.87%) had negative surgical margins. In patients with only apical PSM, stratified by clinical stage, Kaplan-Meier analysis demonstrated significant difference in BCR-free survival between the groups (log rank P<0.001). Multivariable Cox proportional hazards model showed maximal percentage of positive core is the strongest predictor of BCR (HR=3.131, P<0.001). Multivariable Cox proportional hazards model showed PSM is one of the powerful predictor of postoperative BCR (HR=3.123, P<0.001).

Conclusions: PSM after RALP is one of the powerful predictor of BCR and apical PSM is relatively less powerful predictor of BCR. Maximal percentage of positive core is the most powerful preoperative predictors of BCR. Clinical stage and biopsy Gleason score are also associated with pathologic outcomes and BCR free survival rates in patients with positive apical margin only.

Citing Articles

Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review.

Kawase M, Nakane K, Iinuma K, Kawase K, Taniguchi T, Tomioka M J Clin Med. 2024; 13(18).

PMID: 39337047 PMC: 11432447. DOI: 10.3390/jcm13185561.


Analysis of factors associated with positive surgical margins and the five-year survival rate after prostate cancer resection and predictive modeling.

Li K, Zhang Y, Tian S, Su Q, Mei Y, Shi W Front Oncol. 2024; 14:1360404.

PMID: 38903708 PMC: 11187091. DOI: 10.3389/fonc.2024.1360404.


Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX.

Bologna E, Ditonno F, Licari L, Franco A, Manfredi C, Mossack S Clin Pract. 2024; 14(2):508-520.

PMID: 38525718 PMC: 10961791. DOI: 10.3390/clinpract14020039.


Intermediate-term oncological and functional outcomes in prostate cancer patients treated with perineal robot-assisted radical prostatectomy: A single center analysis.

Carbonara U, Lippolis G, Rella L, Minafra P, Guglielmi G, Vitarelli A Asian J Urol. 2023; 10(4):423-430.

PMID: 38024441 PMC: 10659983. DOI: 10.1016/j.ajur.2023.05.005.


Clinicopathological Significances of Positive Surgical Resection Margin after Radical Prostatectomy for Prostatic Cancers: A Meta-Analysis.

Kim M, Yoo D, Pyo J, Cho W Medicina (Kaunas). 2022; 58(9).

PMID: 36143928 PMC: 9500731. DOI: 10.3390/medicina58091251.